Trade HCA Healthcare - HCA CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
- Ownership
Spread | 0.57 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026151% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003929% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
HCA Healthcare Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 243.78 |
Open* | 244.37 |
1-Year Change* | 26.61% |
Day's Range* | 239.86 - 244.37 |
52 wk Range | 178.32-304.86 |
Average Volume (10 days) | 900.55K |
Average Volume (3 months) | 26.22M |
Market Cap | 73.95B |
P/E Ratio | 13.37 |
Shares Outstanding | 271.99M |
Revenue | 61.92B |
EPS | 20.34 |
Dividend (Yield %) | 0.88271 |
Beta | 1.61 |
Next Earnings Date | Oct 19, 2023 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Oct 4, 2023 | 242.94 | -0.02 | -0.01% | 242.96 | 244.64 | 239.69 |
Oct 3, 2023 | 243.78 | 0.42 | 0.17% | 243.36 | 245.50 | 242.23 |
Oct 2, 2023 | 246.89 | 3.11 | 1.28% | 243.78 | 247.09 | 243.63 |
Sep 29, 2023 | 245.69 | -3.12 | -1.25% | 248.81 | 250.10 | 244.27 |
Sep 28, 2023 | 250.31 | 3.11 | 1.26% | 247.20 | 252.33 | 245.38 |
Sep 27, 2023 | 246.99 | -0.58 | -0.23% | 247.57 | 251.42 | 243.27 |
Sep 26, 2023 | 248.25 | -4.24 | -1.68% | 252.49 | 254.08 | 246.99 |
Sep 25, 2023 | 254.26 | 3.95 | 1.58% | 250.31 | 254.68 | 249.50 |
Sep 22, 2023 | 252.00 | 0.43 | 0.17% | 251.57 | 253.95 | 250.95 |
Sep 21, 2023 | 253.15 | 1.50 | 0.60% | 251.65 | 254.96 | 251.56 |
Sep 20, 2023 | 254.07 | 1.11 | 0.44% | 252.96 | 256.12 | 252.96 |
Sep 19, 2023 | 253.98 | 0.36 | 0.14% | 253.62 | 256.95 | 252.42 |
Sep 18, 2023 | 255.42 | 0.88 | 0.35% | 254.54 | 256.96 | 253.28 |
Sep 15, 2023 | 256.04 | -1.58 | -0.61% | 257.62 | 259.34 | 251.83 |
Sep 14, 2023 | 263.32 | 1.60 | 0.61% | 261.72 | 263.94 | 259.82 |
Sep 13, 2023 | 262.21 | 2.52 | 0.97% | 259.69 | 262.52 | 259.06 |
Sep 12, 2023 | 260.61 | -10.25 | -3.78% | 270.86 | 272.22 | 260.53 |
Sep 11, 2023 | 272.23 | -1.03 | -0.38% | 273.26 | 273.38 | 271.52 |
Sep 8, 2023 | 273.42 | 2.82 | 1.04% | 270.60 | 276.87 | 270.59 |
Sep 7, 2023 | 271.52 | -0.96 | -0.35% | 272.48 | 275.35 | 271.11 |
HCA Healthcare Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, October 19, 2023 | ||
Time (UTC) 12:30 | Country US
| Event Q3 2023 HCA Healthcare Inc Earnings Release Q3 2023 HCA Healthcare Inc Earnings ReleaseForecast -Previous - |
Thursday, January 25, 2024 | ||
Time (UTC) 13:30 | Country US
| Event Q4 2023 HCA Healthcare Inc Earnings Release Q4 2023 HCA Healthcare Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 60233 | 58752 | 51533 | 51336 | 46677 |
Revenue | 60233 | 58752 | 51533 | 51336 | 46677 |
Cost of Revenue, Total | 9371 | 9481 | 8369 | 8481 | 7724 |
Gross Profit | 50862 | 49271 | 43164 | 42855 | 38953 |
Total Operating Expense | 51258 | 49086 | 44566 | 44329 | 40044 |
Selling/General/Admin. Expenses, Total | 27685 | 36740 | 33181 | 33041 | 30033 |
Depreciation / Amortization | 2969 | 2853 | 2721 | 2596 | 2278 |
Unusual Expense (Income) | 78 | 12 | 295 | 211 | 9 |
Other Operating Expenses, Total | 11155 | ||||
Operating Income | 8975 | 9666 | 6967 | 7007 | 6633 |
Interest Income (Expense), Net Non-Operating | -1696 | -1453 | -1530 | -1781 | -1726 |
Gain (Loss) on Sale of Assets | 1301 | 1620 | -7 | 18 | 428 |
Net Income Before Taxes | 8580 | 9833 | 5430 | 5244 | 5335 |
Net Income After Taxes | 6834 | 7721 | 4387 | 4145 | 3838 |
Minority Interest | -1191 | -765 | -633 | -640 | -602 |
Net Income Before Extra. Items | 5643 | 6956 | 3754 | 3505 | 3236 |
Net Income | 5643 | 6956 | 3754 | 3505 | 3787 |
Income Available to Common Excl. Extra. Items | 5643 | 6956 | 3754 | 3505 | 3236 |
Income Available to Common Incl. Extra. Items | 5643 | 6956 | 3754 | 3505 | 3787 |
Diluted Net Income | 5643 | 6956 | 3754 | 3505 | 3787 |
Diluted Weighted Average Shares | 294.666 | 328.752 | 343.605 | 348.226 | 355.303 |
Diluted EPS Excluding Extraordinary Items | 19.1505 | 21.1588 | 10.9253 | 10.0653 | 9.10772 |
Diluted Normalized EPS | 15.8446 | 17.3181 | 11.6354 | 10.5034 | 8.25935 |
Total Extraordinary Items | 551 | ||||
Dividends per Share - Common Stock Primary Issue | 2.24 | 1.44 | 1.6 | 1.4 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 15861 | 15591 | 15497 | 14971 | 14820 |
Revenue | 15861 | 15591 | 15497 | 14971 | 14820 |
Cost of Revenue, Total | 2478 | 2423 | 2429 | 2320 | 2301 |
Gross Profit | 13383 | 13168 | 13068 | 12651 | 12519 |
Total Operating Expense | 13561 | 13157 | 13084 | 12828 | 12602 |
Selling/General/Admin. Expenses, Total | 7277 | 7084 | 7055 | 6899 | 9485 |
Depreciation / Amortization | 763 | 756 | 750 | 749 | 738 |
Unusual Expense (Income) | 0 | 0 | 0 | 78 | |
Operating Income | 2300 | 2434 | 2413 | 2143 | 2218 |
Interest Income (Expense), Net Non-Operating | -492 | -497 | -437 | -436 | -426 |
Gain (Loss) on Sale of Assets | 1 | -15 | 1326 | -3 | -32 |
Net Income Before Taxes | 1809 | 1922 | 3302 | 1704 | 1760 |
Net Income After Taxes | 1412 | 1543 | 2646 | 1344 | 1379 |
Minority Interest | -219 | -180 | -565 | -210 | -224 |
Net Income Before Extra. Items | 1193 | 1363 | 2081 | 1134 | 1155 |
Net Income | 1193 | 1363 | 2081 | 1134 | 1155 |
Income Available to Common Excl. Extra. Items | 1193 | 1363 | 2081 | 1134 | 1155 |
Income Available to Common Incl. Extra. Items | 1193 | 1363 | 2081 | 1134 | 1155 |
Diluted Net Income | 1193 | 1363 | 2081 | 1134 | 1155 |
Diluted Weighted Average Shares | 278.198 | 280.961 | 285.558 | 289.852 | 296.061 |
Diluted EPS Excluding Extraordinary Items | 4.28831 | 4.85121 | 7.28749 | 3.91234 | 3.90122 |
Dividends per Share - Common Stock Primary Issue | 0.6 | 0.6 | 0.56 | 0.56 | 0.56 |
Diluted Normalized EPS | 4.28551 | 4.89407 | 3.56647 | 3.9205 | 4.19234 |
Other Operating Expenses, Total | 3043 | 2894 | 2850 | 2860 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 13643 | 13542 | 12333 | 11196 | 10213 |
Cash and Short Term Investments | 908 | 1451 | 1793 | 621 | 502 |
Cash & Equivalents | 908 | 1451 | 1793 | 621 | 502 |
Total Receivables, Net | 8891 | 8095 | 7051 | 7380 | 6789 |
Accounts Receivable - Trade, Net | 8891 | 8095 | 7051 | 7380 | 6789 |
Total Inventory | 2068 | 1986 | 2025 | 1849 | 1732 |
Other Current Assets, Total | 1776 | 2010 | 1464 | 1346 | 1190 |
Total Assets | 52438 | 50742 | 47490 | 45058 | 39207 |
Property/Plant/Equipment, Total - Net | 27640 | 26176 | 25223 | 24549 | 19757 |
Property/Plant/Equipment, Total - Gross | 56822 | 53463 | 51341 | 49069 | 42965 |
Accumulated Depreciation, Total | -29182 | -27287 | -26118 | -24520 | -23208 |
Goodwill, Net | 9653 | 9540 | 8578 | 8269 | 7953 |
Long Term Investments | 1204 | 886 | 810 | 564 | 594 |
Other Long Term Assets, Total | 298 | 598 | 546 | 480 | 690 |
Total Current Liabilities | 9902 | 9582 | 8704 | 7757 | 7569 |
Accounts Payable | 4239 | 4111 | 3535 | 2905 | 2577 |
Accrued Expenses | 5212 | 5234 | 4960 | 4707 | 4204 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 370 | 237 | 209 | 145 | 788 |
Total Liabilities | 55205 | 51675 | 46918 | 47866 | 44157 |
Total Long Term Debt | 37714 | 34342 | 30795 | 33577 | 32033 |
Long Term Debt | 37135 | 33765 | 30301 | 33107 | 32033 |
Minority Interest | 2694 | 2422 | 2320 | 2243 | 2032 |
Other Liabilities, Total | 4895 | 5329 | 5099 | 4289 | 2523 |
Total Equity | -2767 | -933 | 572 | -2808 | -4950 |
Common Stock | 3 | 3 | 3 | 3 | 3 |
Retained Earnings (Accumulated Deficit) | -2280 | -532 | 777 | -2351 | -4572 |
Unrealized Gain (Loss) | -30 | 12 | 25 | 14 | 3 |
Other Equity, Total | -460 | -416 | -527 | -474 | -384 |
Total Liabilities & Shareholders’ Equity | 52438 | 50742 | 47490 | 45058 | 39207 |
Total Common Shares Outstanding | 277.378 | 305.477 | 339.426 | 338.446 | 342.895 |
Capital Lease Obligations | 579 | 577 | 494 | 470 | |
Additional Paid-In Capital | 0 | 294 | |||
Other Current Liabilities, Total | 81 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Total Current Assets | 13541 | 13643 | 13481 | 13937 | 15006 |
Cash and Short Term Investments | 842 | 908 | 999 | 858 | 2371 |
Cash & Equivalents | 842 | 908 | 999 | 858 | 2371 |
Total Receivables, Net | 8657 | 8891 | 8552 | 8628 | 8520 |
Accounts Receivable - Trade, Net | 8657 | 8891 | 8552 | 8628 | 8520 |
Total Inventory | 2085 | 2068 | 2009 | 2043 | 2003 |
Other Current Assets, Total | 1957 | 1776 | 1921 | 2408 | 2112 |
Total Assets | 52711 | 52438 | 51484 | 51584 | 52208 |
Property/Plant/Equipment, Total - Net | 28085 | 27640 | 27075 | 26726 | 26366 |
Property/Plant/Equipment, Total - Gross | 55463 | 54757 | 53730 | 52816 | 52042 |
Accumulated Depreciation, Total | -29410 | -29182 | -28752 | -28229 | -27814 |
Goodwill, Net | 9590 | 9653 | 9651 | 9593 | 9525 |
Long Term Investments | 1176 | 1204 | 816 | 814 | 849 |
Other Long Term Assets, Total | 319 | 298 | 461 | 514 | 462 |
Total Current Liabilities | 11028 | 9902 | 9784 | 8999 | 10518 |
Accounts Payable | 3769 | 4239 | 4161 | 3742 | 4010 |
Accrued Expenses | 4881 | 5293 | 5405 | 5011 | 5022 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 2378 | 370 | 218 | 246 | 1486 |
Total Liabilities | 55206 | 55205 | 54854 | 55264 | 54241 |
Total Long Term Debt | 36478 | 37714 | 37492 | 38657 | 36210 |
Long Term Debt | 36478 | 37714 | 37492 | 38657 | 36210 |
Minority Interest | 2727 | 2694 | 2592 | 2538 | 2447 |
Other Liabilities, Total | 4973 | 4895 | 4986 | 5070 | 5066 |
Total Equity | -2495 | -2767 | -3370 | -3680 | -2033 |
Common Stock | 3 | 3 | 3 | 3 | 3 |
Additional Paid-In Capital | |||||
Retained Earnings (Accumulated Deficit) | -2028 | -2280 | -2781 | -3168 | -1589 |
Unrealized Gain (Loss) | -25 | -30 | -32 | -20 | -8 |
Other Equity, Total | -445 | -460 | -560 | -495 | -439 |
Total Liabilities & Shareholders’ Equity | 52711 | 52438 | 51484 | 51584 | 52208 |
Total Common Shares Outstanding | 275.94 | 277.378 | 283.904 | 287.004 | 298.981 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | 6834 | 7721 | 4387 | 4145 | 4389 |
Cash From Operating Activities | 8522 | 8959 | 9232 | 7602 | 6761 |
Cash From Operating Activities | 2969 | 2853 | 2721 | 2596 | 2278 |
Non-Cash Items | -129 | -1112 | 846 | 949 | 61 |
Cash Taxes Paid | 1175 | 2182 | 1002 | 849 | 872 |
Cash Interest Paid | 1662 | 1502 | 1607 | 1914 | 1744 |
Changes in Working Capital | -1152 | -503 | 1278 | -88 | 33 |
Cash From Investing Activities | -3389 | -2643 | -3393 | -5720 | -3901 |
Capital Expenditures | -4395 | -3577 | -2835 | -4158 | -3573 |
Other Investing Cash Flow Items, Total | 1006 | 934 | -558 | -1562 | -328 |
Cash From Financing Activities | -5656 | -6655 | -4677 | -1771 | -3075 |
Financing Cash Flow Items | -1290 | -1071 | -866 | -757 | -714 |
Issuance (Retirement) of Stock, Net | -7000 | -8215 | -441 | -1031 | -1530 |
Issuance (Retirement) of Debt, Net | 3287 | 3255 | -3217 | 567 | -344 |
Net Change in Cash | -543 | -342 | 1172 | 119 | -230 |
Total Cash Dividends Paid | -653 | -624 | -153 | -550 | -487 |
Foreign Exchange Effects | -20 | -3 | 10 | 8 | -15 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | 1543 | 6834 | 4188 | 2844 | 1465 |
Cash From Operating Activities | 1803 | 8522 | 5995 | 2975 | 1345 |
Cash From Operating Activities | 756 | 2969 | 2219 | 1470 | 732 |
Non-Cash Items | 546 | -129 | 666 | 488 | 467 |
Cash Taxes Paid | 7 | 1175 | 931 | 609 | 3 |
Cash Interest Paid | 574 | 1662 | 1329 | 777 | 408 |
Changes in Working Capital | -1042 | -1152 | -1078 | -1827 | -1319 |
Cash From Investing Activities | -1151 | -3389 | -2596 | -2050 | -845 |
Capital Expenditures | -1197 | -4395 | -3072 | -1941 | -861 |
Other Investing Cash Flow Items, Total | 46 | 1006 | 476 | -109 | 16 |
Cash From Financing Activities | -725 | -5656 | -3818 | -1501 | 425 |
Financing Cash Flow Items | -394 | -1290 | -812 | -587 | -417 |
Total Cash Dividends Paid | -175 | -653 | -497 | -337 | -177 |
Issuance (Retirement) of Stock, Net | -846 | -7000 | -5481 | -4783 | -2101 |
Issuance (Retirement) of Debt, Net | 690 | 3287 | 2972 | 4206 | 3120 |
Foreign Exchange Effects | 7 | -20 | -33 | -17 | -5 |
Net Change in Cash | -66 | -543 | -452 | -593 | 920 |
Investor Name | Investor Type | Percent Outstanding | Shares Held | Shares change | Holdings Date | Turnover Rating |
---|---|---|---|---|---|---|
Hercules Holding II | Corporation | 25.3364 | 68912077 | 0 | 2022-12-31 | |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 6.3909 | 17382362 | -397097 | 2023-06-30 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 4.0296 | 10960076 | -1935280 | 2023-06-30 | LOW |
Sanders Capital, LLC | Investment Advisor | 4.0221 | 10939667 | 354323 | 2023-06-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 3.4299 | 9329023 | -37317 | 2023-06-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 3.2999 | 8975423 | 149750 | 2023-06-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 2.0106 | 5468654 | -2217583 | 2023-06-30 | LOW |
First Eagle Investment Management, L.L.C. | Investment Advisor/Hedge Fund | 1.6752 | 4556365 | -32653 | 2023-06-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 1.3974 | 3800828 | -12133 | 2023-06-30 | LOW |
JP Morgan Asset Management | Investment Advisor | 1.3507 | 3673874 | 8827 | 2023-06-30 | LOW |
Harris Associates L.P. | Investment Advisor/Hedge Fund | 1.1079 | 3013323 | -1925369 | 2023-06-30 | LOW |
Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 1.1008 | 2993971 | 1531395 | 2023-06-30 | MED |
Longview Partners LLP | Investment Advisor/Hedge Fund | 0.9343 | 2541230 | -61602 | 2023-06-30 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 0.8383 | 2279978 | 227886 | 2022-12-31 | LOW |
Fidelity Management & Research Company LLC | Investment Advisor | 0.6359 | 1729670 | -2084 | 2023-06-30 | LOW |
RBC Global Asset Management (UK) Limited | Investment Advisor | 0.6 | 1632016 | 1632016 | 2023-06-30 | LOW |
Nuveen LLC | Pension Fund | 0.5844 | 1589508 | 44280 | 2023-06-30 | LOW |
BlackRock Asset Management Ireland Limited | Investment Advisor | 0.5761 | 1566884 | -3457 | 2023-06-30 | LOW |
Diamond Hill Capital Management Inc. | Investment Advisor/Hedge Fund | 0.5651 | 1536954 | -87189 | 2023-06-30 | LOW |
Royal London Asset Management Ltd. | Investment Advisor/Hedge Fund | 0.5259 | 1430484 | 107029 | 2023-06-30 | MED |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
HCA Healthcare Company profile
HCA Holdings Inc. (HCA) is an American provider of healthcare services, located in Nashville, Tennessee. Founded in1968, the company operates around 170 hospitals and 118 surgery centers offering medical, surgical, psychiatric, rehabilitation, and outpatient healthcare services. HCA Holdings operates in 20 US states and in the United Kingdom, and employs approximately 233,000 staff members. HCA Holdings Inc. is listed on the New York Stock Exchange (NYSE) and is an S&P 500 component. Get the Healthcare share price at Capital.com.Industry: | Healthcare Facilities & Services (NEC) |
1 Park Plz
NASHVILLE
TENNESSEE 37203-6527
US
Income Statement
- Annual
- Quarterly
News

How to Trade The Triple Top
Welcome to Part 5 of our 7-part Power Patterns series. In this series, we'll be equipping you with the skills to trade some of the most indicative price patterns which occur on any timeframe in every market.
14:13, 27 September 2023
Q4 lookahead: US indices starting to show signs of trouble?
US indices start to draw attention as traders focus on the outlook for Q4.
07:20, 27 September 2023
USD/JPY Climbs Towards Key Highs
USDJPY’s powerful long-term uptrend has been reignited after last week’s sharply contrasting policy statements from the Federal Reserve and Bank of Japan.
11:32, 26 September 2023
EUR/USD tests key support
EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.
14:32, 21 September 2023
BoE leaves rates unchanged, GBP drops further as investors look for more clarity
The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August
11:45, 21 September 2023
GBP softer after CPI surprise, JPY focused on any further hints from Ueda
GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.
12:42, 20 September 2023
How to Trade The Break & Retest
In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.
11:59, 20 September 2023People also watch
Still looking for a broker you can trust?
Join the 555.000+ traders worldwide that chose to trade with Capital.com